Proactive Investors - Run By Investors For Investors

Constellation Healthcare Technologies beefs up board

Dr Zimberg was one of the founding partners of a biotech-focused merchant bank
Constellation Healthcare Technologies beefs up board
Dr Zimberg is a highly-respected radiation oncology specialist

US-based healthcare services provider Constellation Healthcare Technologies (LON:CHT) has appointed highly respected physician Dr Shawn Zimberg to the board as a non-executive director.

Dr Zimberg is the medical director of Advanced Radiation Centers of New York, a division of Integrated Medical Professionals, and has served on the board of Integrated Medical Professionals since July 2006.

Constellation said he is a leading expert in the field or radiation oncology. He was also one of the founding partners of Evolution Partners, a merchant and investment bank focused on life sciences, biotechnology and healthcare & wellness industries.

"He is a highly respected physician and entrepreneur. His addition will help us greatly as we pursue our strategy of being one of the leading healthcare services and technology businesses in the US,” said Paul Parmar, chief executive officer of Constellation.

“Constellation will benefit from his medical insight, especially in the billing and practice management verticals of our business. Constellation will also gain from Dr Zimberg's broader knowledge of the US healthcare sector, its pressure points and how the company can optimise its positioning in-front of the medical community, " Parmar added.

View full CHT profile View Profile

Constellation Healthcare Technologies, Inc. Timeline

Related Articles

picture of addict
November 15 2017
To build the UK's first £1bn, self-sustainable biotech is the aim for chief executive Clive Dix
Frosties Box
December 04 2017
The company is a pioneer in the human microbiome, which is essentially the bacteria that inhabits the gut and skin
November 29 2017
The company has developed a "unique and superior pressure" cycling technology (PCT), says Zacks.

No investment advice

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

© Proactive Investors 2018

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use